Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Oku

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Rheumatic Diseases|July 9, 2026
The Impact of Exercise Tolerance Assessed by 6-Min Walking Distance on Clinical Outcomes in Patients With Interstitial Lung Disease Associated With Connective Tissue DiseasesHidenori Kariya, Kenji Oku, Yoshikazu Suzuki, et al.
Rheumatology (Oxford, England)|July 24, 2013
Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibodyKenji Oku, Olga Amengual, Polona Zigon, et al.
Modern Rheumatology|April 25, 2012
Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndromeOlga Amengual, Tatsuya Atsumi, Kenji Oku, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|March 12, 2008
[A case of maternally inherited diabetes with deafness (MIDD) occurring at an advanced age]Jun Takeuchi, Jun Tashiro, Osamu Nakagaki, et al.
Modern Rheumatology|June 5, 2025
A retrospective chart review to explore the efficacy and safety of switching to peficitinib in Japanese patients with rheumatoid arthritis and inadequate response to biologic disease-modifying antirheumatic drugsKunihiro Yamaoka, Junichi Kondo, Toshinori Furuya, et al.
Modern Rheumatology|April 11, 2014
Decreased expression of Runx1 and lowered proportion of Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells in systemic sclerosisHiroshi Kataoka, Shinsuke Yasuda, Shinji Fukaya, et al.
Drug Discoveries & Therapeutics|September 5, 2017
Successful treatment of three patients with organizing pneumonia associated with rheumatoid arthritis using clarithromycin and prednisoloneMasashi Ohe, Haruki Shida, Tetsuya Horita, et al.
Modern Rheumatology|September 6, 2022
Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nationwide JCR COVID-19 registry in JapanKenji Oku, Yasutaka Kimoto, Takahiko Horiuchi, et al.
Modern Rheumatology Case Reports|October 7, 2023
A case of dupilumab combination therapy for exacerbation of atopic dermatitis in a patient with eosinophilic granulomatosis with polyangiitis treated with mepolizumabYosuke Iwadate, Yoshiyuki Arinuma, Yu Matsueda, et al.
International Journal of Rheumatic Diseases|August 2, 2022
Management of non-renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statementsNuntana Kasitanon, Laniyati Hamijoyo, Meng Tao Li, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Rheumatic Diseases|July 9, 2026
The Impact of Exercise Tolerance Assessed by 6-Min Walking Distance on Clinical Outcomes in Patients With Interstitial Lung Disease Associated With Connective Tissue DiseasesHidenori Kariya, Kenji Oku, Yoshikazu Suzuki, et al.
Rheumatology (Oxford, England)|July 24, 2013
Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibodyKenji Oku, Olga Amengual, Polona Zigon, et al.
Modern Rheumatology|April 25, 2012
Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndromeOlga Amengual, Tatsuya Atsumi, Kenji Oku, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|March 12, 2008
[A case of maternally inherited diabetes with deafness (MIDD) occurring at an advanced age]Jun Takeuchi, Jun Tashiro, Osamu Nakagaki, et al.
Modern Rheumatology|June 5, 2025
A retrospective chart review to explore the efficacy and safety of switching to peficitinib in Japanese patients with rheumatoid arthritis and inadequate response to biologic disease-modifying antirheumatic drugsKunihiro Yamaoka, Junichi Kondo, Toshinori Furuya, et al.
Modern Rheumatology|April 11, 2014
Decreased expression of Runx1 and lowered proportion of Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells in systemic sclerosisHiroshi Kataoka, Shinsuke Yasuda, Shinji Fukaya, et al.
Drug Discoveries & Therapeutics|September 5, 2017
Successful treatment of three patients with organizing pneumonia associated with rheumatoid arthritis using clarithromycin and prednisoloneMasashi Ohe, Haruki Shida, Tetsuya Horita, et al.
Modern Rheumatology|September 6, 2022
Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nationwide JCR COVID-19 registry in JapanKenji Oku, Yasutaka Kimoto, Takahiko Horiuchi, et al.
Modern Rheumatology Case Reports|October 7, 2023
A case of dupilumab combination therapy for exacerbation of atopic dermatitis in a patient with eosinophilic granulomatosis with polyangiitis treated with mepolizumabYosuke Iwadate, Yoshiyuki Arinuma, Yu Matsueda, et al.
International Journal of Rheumatic Diseases|August 2, 2022
Management of non-renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statementsNuntana Kasitanon, Laniyati Hamijoyo, Meng Tao Li, et al.
Pageof 9